Trademark: 90560221
Word
Q MOLECULE TO CURE. FAST.
Status
Registered
Status Code
700
Status Date
Tuesday, November 15, 2022
Serial Number
90560221
Registration Number
6898033
Registration Date
Tuesday, November 15, 2022
Mark Type
3000
Filing Date
Thursday, March 4, 2021
Published for Opposition
Tuesday, August 30, 2022

Trademark Owner History
Quotient Sciences Limited - Original Registrant

Classifications
40 Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely, manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely, providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing
39 Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for others, namely, contract packaging services in the nature of merchandise packaging for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials, namely, contract packaging services in the nature of pharmaceutical, biopharmaceutical and clinical supplies and materials packaging for others
42 Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science, namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely, development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely, conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely, technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals
The mark consists of two light grey squares next to each other. The square on the left contains a semi-circular navy blue curved line with light blue molecules floating from the semi-circle and the navy blue letter "Q" overlayed on top of the design. The square on the right contains a word-stacked stylization of the black wording "MOLECULE" on top of the black wording "TO CURE", both of which are on top of the black wording "FAST". All instances of the color white represent a background and are not claimed as a feature of the mark.
QUOTIENT MOLECULE TO CURE. FAST.
The color(s) navy blue, light blue, grey and black are included as a feature of the mark or legal equivalent in the foreign registration. Similarly, in the U.S. application, the colors navy blue, light blue, grey and black is/are claimed as a feature of the mark.

Trademark Events
Nov 15, 2022
Notice Of Registration Confirmation Emailed
Nov 15, 2022
Registered-Principal Register
Aug 30, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2022
Published For Opposition
Aug 10, 2022
Notification Of Notice Of Publication E-Mailed
Jul 26, 2022
Approved For Pub - Principal Register
Jul 25, 2022
Teas/Email Correspondence Entered
Jul 25, 2022
Correspondence Received In Law Office
Jul 25, 2022
Teas Response To Office Action Received
Jun 13, 2022
Notification Of Non-Final Action E-Mailed
Jun 13, 2022
Non-Final Action E-Mailed
Jun 13, 2022
Non-Final Action Written
May 9, 2022
Teas/Email Correspondence Entered
May 9, 2022
Correspondence Received In Law Office
Apr 29, 2022
Assigned To Lie
Apr 26, 2022
Teas Response To Office Action Received
Oct 29, 2021
Notification Of Non-Final Action E-Mailed
Oct 29, 2021
Non-Final Action E-Mailed
Oct 29, 2021
Non-Final Action Written
Sep 27, 2021
Assigned To Examiner
Jun 4, 2021
Notice Of Design Search Code E-Mailed
Jun 3, 2021
New Application Office Supplied Data Entered In Tram
Mar 8, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24